Delivery Order SPE2DB22D2007-SPE2DB23FJ1TA
Award Date 4/20/23
Potential Completion Date 4/21/23
Potential Value $4.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,260, is a delivery order for the medication Mounjaro 7.5 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of November 15, 2024 and is a firm fixed price contract. AmerisourceBergen Drug Corp is the prime contractor, and the contract was not designated with a set-aside...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,572.11, is for the delivery of the medication Mounjaro 5 mg/0.5 ml pen 0.5 ml. The contract is a firm fixed-price delivery order with a period of performance through May 22, 2025. The contract is not set-aside and was awarded on an open competition basis. AmerisourceBergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.54, is for the delivery of the medication Mounjaro 15 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price contract. AmerisourceBergen is the prime contractor, and there is no set-aside designation indicated. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to AmerisourceBergen Drug Corp. for the medication Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml). The award has a ceiling value of $1,668.36 and a total completion date of August 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a variety of critical medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,836.38, is for the procurement of the medication Mounjaro 5 mg/0.5 ml pen in 0.5 ml quantities. The award has an ultimate completion date of May 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,103.95, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 20, 2025. The contract was awarded on February 19, 2025 and does not have a set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,812.57, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 5, 2024. The contract does not have a set-aside designation, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,688.06, is for the delivery of the drug MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on March 31, 2025. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro (5 mg/0.5 ml pen, 0.5 ml) with a ceiling value of $3,209.65 and an ultimate completion date of October 10, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,260.00, is for the delivery of the medication "MOUNJARO 5 MG/0.5 ML PEN 0.5ML" with a completion date of November 18, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...